Evidence map›Paper›PMID 19370768›Full record

ArticleHuman mutation2009

Molecular mechanisms of classical Ehlers-Danlos syndrome (EDS).

Anna L Mitchell, Ulrike Schwarze, Jessica F Jennings, Peter H Byers

Abstract read
In one paragraph

Article in Human mutation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Ready or not, genomic screening of fetuses is already here.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Biomarkers for Ehlers-Danlos Syndromes: There Is a Role?International journal of molecular sciences · 2021
    Review
  8. A Heterozygous Missense Variant in theAnimals : an open access journal from MDPI · 2020
    Article
  9. Article
  10. Genetic Aspects in Shoulder Disorders.Revista brasileira de ortopedia · 2020
    Article
  11. Article
  12. New variants inPostepy dermatologii i alergologii · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Anna L MitchellDepartment of Pediatrics, Division of Genetics, University of Washington, Seattle, WA, USA. alm43@case.edu
Ulrike Schwarze
Jessica F Jennings
Peter H Byers
University of Washington · USUniversity of Washington Medical Center · US

Funding

Medical Genetics Training GrantT32GM007454 · NIGMS · UNIVERSITY OF WASHINGTON · PI Gail Pairitz Jarvik, Andrew Ben Stergachis · 1985 to 2026
$6.9M
Cellular and Molecular Biology of Childhood DiseaseK12HD043376 · NICHD · UNIVERSITY OF WASHINGTON · PI STAPLETON, FIELDING BRUDER · 2003 to 2012
$3.3M
STRUCTURAL PROTEINS IN DISORDERS OF KERATINIZATIONP01AR021557 · NIAMS · UNIVERSITY OF WASHINGTON · PI STEPHENS, KAREN G · 1986 to 2001
$2.8M
Molecular Analysis in Classical Ehlers-Danlos SyndromeK23AR051444 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI MITCHELL, ANNA L · 2004 to 2009
$628k
NIAMS NIH HHS AR051444NIAMS NIH HHS AR21557NIAMS NIH HHS K23 AR051444NIAMS NIH HHS P01 AR021557NICHD NIH HHS HD043376NICHD NIH HHS K12 HD043376NIGMS NIH HHS 2 T32 GM 007454-31NIGMS NIH HHS T32 GM007454
6 · The paper itself

Abstract

Classical Ehlers-Danlos syndrome (EDS) is a heritable disorder characterized by joint hypermobility, skin hyperextensibility, and abnormal wound healing. The majority of affected individuals have alterations in 1 of the 2 type V collagen genes, COL5A1 and COL5A2. The most common mechanism is COL5A1 haploinsufficiency due to instability of the transcript of one allele. In dermal fibroblasts from our population of 76 individuals with clinical features of classical EDS, there were 21 (29.5%) with decreased expression of one COL5A1 allele, consistent with published estimates of the frequency of null alleles. We identified the causative mutation in nine of these cell strains (mutations for seven others had been previously described), and found two nonsense mutations, five splice mutations, and two insertion/deletions. The same type of genomic change at splice sites can have different effects at the RNA level and the outcome could not be predicted from the primary genomic DNA alteration.

Indexed as

AllelesCollagen Type VDNA, ComplementaryEhlers-Danlos SyndromeElectrophoresis, Polyacrylamide GelExonsGene FrequencyGenome, HumanHumansMutationRNA Splice SitesRNA SplicingSequence Analysis, DNACOL5A1 protein, humanCollagen Type VDNA, ComplementaryRNA Splice Sites

Identifiers

PMID19370768
PMCPMC3827857
OpenAlexW2058940571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.